HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Criminal Case In PR, FTC Appeal In NY, GNC In India: Health And Wellness Industry News

This article was originally published in The Rose Sheet

Executive Summary

GNC works with Guardian Healthcare Services to grow sales in India; FTC, NY AG appeal dismissal of Prevagen complaint; and a federal grand jury in San Juan returned a 28-count indictment charging four defendants with mail and wire fraud , trafficking in counterfeit goods, distributing a controlled substance, international money laundering and smuggling.

You may also be interested in...



Same Brands, Different Defendant In Puerto Rico Spiked-Supplement Charges

Some unlawful products businessman Sameer Bani is accused of selling are branded with same names and contained same undisclosed APIs as products the US Attorney's Office for Puerto Rico seized in 2018 from four defendants following a separate investigation by FDA.

FTC's Prevagen Complaint Revived: Court Says 'Deceptive' Ad Allegation Plausible

District court erred in dismissing FTC complaint that Prevagen marketer Quincy Biosciences used deceptive representations in ads, Second Circuit says in long-awaited order. FTC and New York attorney general, along with advocacy group TINA, criticize Quincy's post hoc data analyses finding "false positives."

Imposing RCTs For Supplement Claims Would Cause 'Wholesale Change' In Regulation – CRN, CHPA

“The industry would face confusion as to the appropriate substantiation standard for non-disease dietary supplement claims,” say the Council for Responsible Nutrition and the Consumer Healthcare Products Association in a joint amicus brief filed with in Second Circuit. They submitted the brief in support of Quincy’s motion urging the appeals court to dismiss an appeal by FTC and New York of a federal district court’s 2017 dismissal of the federal and state agencies' complaint against Quincy.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121503

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel